ArticleDermatology and therapy2025

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.

Julien Seneschal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.